Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Sinusoidal obstruction syndrome following CD33-targeted therapy in acute myeloid leukemia

Colin D. Godwin, George B. McDonald, Roland B. Walter

Blood (2017) 129 (16): 2330–2332.

https://doi.org/10.1182/blood-2017-01-762419

Published: 2017

Journal Articles

How I treat hepatitis C virus infection in patients with hematologic malignancies

Harrys A. Torres, George B. McDonald

Blood (2016) 128 (11): 1449–1457.

https://doi.org/10.1182/blood-2016-05-718643

Published: 2016

Journal Articles

How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver

George B. McDonald

Blood (2016) 127 (12): 1544–1550.

https://doi.org/10.1182/blood-2015-10-612747

Published: 2016

Journal Articles

Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment

George B. McDonald, Laura Tabellini, Barry E. Storer, Richard L. Lawler, Paul J. Martin, John A. Hansen

Blood (2015) 126 (1): 113–120.

https://doi.org/10.1182/blood-2015-03-636753

Published: 2015

Includes: Supplemental data

Journal Articles

Efficacy and Safety Of Lower-Dose Glucocorticoids For Initial Treatment Of Acute Graft-Versus-Host Disease: A Randomized Controlled Trial

Marco Mielcarek, MD, Terrence Furlong, Barry E. Storer, PhD, Margaret L. Green, MD, Paul A. Carpenter, MD, George B McDonald, MD, Mary E. D. Flowers, MD, Rainer Storb, MD, Frederick R. Appelbaum, MD, Michael Boeckh, MD, Paul J. Martin, MD

Blood (2013) 122 (21): 703.

https://doi.org/10.1182/blood.V122.21.703.703

Published: 2013

Journal Articles

Crohn disease: remissions but no cure

Richard A. Nash, George B. McDonald

Blood (2010) 116 (26): 5790–5791.

https://doi.org/10.1182/blood-2010-09-309252

Published: 2010

Journal Articles

Low Toxicity and Mortality with Reversed-Order Conditioning (Cyclophosphamide Followed by Targeted Intravenous Busulfan) in Allogeneic Hematopoietic Cell Transplantation: Preliminary Results of a Prospective Clinical Trial.

Andrew R. Rezvani, MD, Jeannine S. McCune, PhD, Ami Batchelder, Barry E. Storer, PhD, George B. McDonald, MD, H. Joachim Deeg, MD

Blood (2009) 114 (22): 1175.

https://doi.org/10.1182/blood.V114.22.1175.1175

Published: 2009

Journal Articles

Falling Serum Albumin Predicts Severity of Acute Graft-Vs.-Host Disease and Non-Relapse Mortality After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation.

Andrew R. Rezvani, MD, Barry E. Storer, PhD, Rainer F. Storb, MD, Marco Mielcarek, MD, David G. Maloney, MD, PhD, Brenda M. Sandmaier, MD, Paul J. Martin, MD, Mary E. D. Flowers, MD, George B. McDonald, MD

Blood (2009) 114 (22): 1146.

https://doi.org/10.1182/blood.V114.22.1146.1146

Published: 2009

Journal Articles

Contrast Enhanced Ultrasound Sonography in Intestinal Acute Graft Versus Host Disease: Advantages of Non-Invasive Anatomic and Physiologic Measurements.

Edoardo Benedetti, Benedetto Bruno, MD, PhD, George B. McDonald, MD, Francesco Caracciolo, Federico Papineschi, Matteo Pelosini, Daniele Focosi, M.D., Sara Galimberti, Mario Petrini, MD

Blood (2009) 114 (22): 4493.

https://doi.org/10.1182/blood.V114.22.4493.4493

Published: 2009

Journal Articles

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes

Marco Mielcarek, Barry E. Storer, Michael Boeckh, Paul A. Carpenter, George B. McDonald, H. Joachim Deeg, Richard A. Nash, Mary E. D. Flowers, Kristine Doney, Stephanie Lee, Kieren A. Marr, Terry Furlong, Rainer Storb, Frederick R. Appelbaum, Paul J. Martin

Blood (2009) 113 (13): 2888–2894.

https://doi.org/10.1182/blood-2008-07-168401

Published: 2009

Includes: Supplemental data

Journal Articles

Prognostic Factors and Outcomes of Severe Gastrointestinal Graft Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation

Cristina Castilla-LLorente, MD., PHD., Richard A. Nash, MD, George B McDonald, Barry E. Storer, PhD, Paul J. Martin, MD

Blood (2008) 112 (11): 4341.

https://doi.org/10.1182/blood.V112.11.4341.4341

Published: 2008

Journal Articles

Incidence of Sinusoidal Obstruction Syndrome Following Mylotarg (Gemtuzumab Ozogamicin, GO): a Prospective Observational Study in Routine Clinical Practice.

Marti n S Tallman, George B McDonald, Laurie D DeLeve, Eliot Obi-Tabot, Carl Kollmer, Jay M Feingold

Blood (2008) 112 (11): 956.

https://doi.org/10.1182/blood.V112.11.956.956

Published: 2008

Journal Articles

In Patients with Aplastic Anaemia, Conditioning with Reduced Intensity Followed by Infusion of T-Cell Depleted Grafts Is Associated with Limited Transplant Related Morbidity and Universal Survival.

Nicolas Novitzky, MD, PhD, Valda Thomas, Dip Med Tech, Cecile E. Du Toit, MBChB, MMed, Andrew B. McDonald, MBChB, FCP

Blood (2007) 110 (11): 3289.

https://doi.org/10.1182/blood.V110.11.3289.3289

Published: 2007

Journal Articles

Increasing Anthracycline Dose during Induction Chemotherapy Leads to Higher Remission Rates in Acute Myelogenous Leukaemia (AML).

Nicolas Novitzky, MD, PhD, Cecile E. Du Toit, MBChB,MMed, Andrew B. McDonald, MBChB;FCP

Blood (2007) 110 (11): 4388.

https://doi.org/10.1182/blood.V110.11.4388.4388

Published: 2007

Journal Articles

A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease

David M. Hockenbery, Scott Cruickshank, Timothy C. Rodell, Ted Gooley, Friedrich Schuening, Scott Rowley, Donald David, Mark Brunvand, Brian Berryman, Sunil Abhyankar, Michelle Bouvier, George B. McDonald, for the orBec GVHD Study Group

Blood (2007) 109 (10): 4557–4563.

https://doi.org/10.1182/blood-2006-05-021139

Published: 2007

Includes: Supplemental data

Journal Articles

An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens

Wendy M. Leisenring, Paul J. Martin, Effie W. Petersdorf, Anne E. Regan, Nada Aboulhosn, Jean M. Stern, Saundra N. Aker, Raymond C. Salazar, George B. McDonald

Blood (2006) 108 (2): 749–755.

https://doi.org/10.1182/blood-2006-01-0254

Published: 2006

Journal Articles

Defibrotide (DF) for the Treatment of Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Analysis of Response and Survival According to Degree and Type of MOF.

Blood (2005) 106 (11): 399.

https://doi.org/10.1182/blood.V106.11.399.399

Published: 2005

Journal Articles

Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Final Results of a Phase II, Multicenter, Randomized Study and Preliminary Analyses of Surrogate Markers and Ultrasound Findings.

Blood (2004) 104 (11): 350.

https://doi.org/10.1182/blood.V104.11.350.350

Published: 2004

Journal Articles

Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation

Kristina M. Adams, Leona A. Holmberg, Wendy Leisenring, Alexander Fefer, Katherine A. Guthrie, Tracy S. Tylee, George B. McDonald, William I. Bensinger, J. Lee Nelson

Blood (2004) 104 (6): 1894–1897.

https://doi.org/10.1182/blood-2004-02-0508

Published: 2004

Journal Articles

A silent epidemic in survivors of hematopoietic cell transplantation

George B. McDonald

Blood (2004) 103 (5): 1569.

https://doi.org/10.1182/blood-2003-12-4270

Published: 2004

NARROW

Sinusoidal obstruction syndrome following CD33-targeted therapy in acute myeloid leukemia

How I treat hepatitis C virus infection in patients with hematologic malignancies

How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver

Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment

Efficacy and Safety Of Lower-Dose Glucocorticoids For Initial Treatment Of Acute Graft-Versus-Host Disease: A Randomized Controlled Trial

Crohn disease: remissions but no cure

Low Toxicity and Mortality with Reversed-Order Conditioning (Cyclophosphamide Followed by Targeted Intravenous Busulfan) in Allogeneic Hematopoietic Cell Transplantation: Preliminary Results of a Prospective Clinical Trial.

Falling Serum Albumin Predicts Severity of Acute Graft-Vs.-Host Disease and Non-Relapse Mortality After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation.

Contrast Enhanced Ultrasound Sonography in Intestinal Acute Graft Versus Host Disease: Advantages of Non-Invasive Anatomic and Physiologic Measurements.

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes

Prognostic Factors and Outcomes of Severe Gastrointestinal Graft Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation

Incidence of Sinusoidal Obstruction Syndrome Following Mylotarg (Gemtuzumab Ozogamicin, GO): a Prospective Observational Study in Routine Clinical Practice.

In Patients with Aplastic Anaemia, Conditioning with Reduced Intensity Followed by Infusion of T-Cell Depleted Grafts Is Associated with Limited Transplant Related Morbidity and Universal Survival.

Increasing Anthracycline Dose during Induction Chemotherapy Leads to Higher Remission Rates in Acute Myelogenous Leukaemia (AML).

A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease

An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens

Defibrotide (DF) for the Treatment of Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Analysis of Response and Survival According to Degree and Type of MOF.

Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Final Results of a Phase II, Multicenter, Randomized Study and Preliminary Analyses of Surrogate Markers and Ultrasound Findings.

Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation

A silent epidemic in survivors of hematopoietic cell transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only